We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+275.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$223M
AUM Growth
+$77.2M
Cap. Flow
+$50.2M
Cap. Flow %
22.55%
Top 10 Hldgs %
25.3%
Holding
464
New
223
Increased
67
Reduced
60
Closed
103

Top Buys

Rank Stock Value
1
MOH icon
Molina Healthcare
MOH
+$8.43M
2
ELV icon
Elevance Health
ELV
+$5.15M
3
INTC icon
Intel
INTC
+$4.26M
4
SNDK
Sandisk
SNDK
+$3.61M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.5M

Sector Composition

Rank Sector Weight
1 Healthcare 52.36%
2 Technology 13.57%
3 Financials 11.27%
4 Miscellaneous 7.53%
5 Communication Services 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OVID icon
426
Ovid Therapeutics
OVID
$547M
-46,040
Closed -$59.9K
PGY icon
427
CALL
Pagaya Technologies
PGY
$1.92B
-32
Closed -$8.94K
PGY icon
428
Pagaya Technologies
PGY
$1.92B
-30,839
Closed -$916K
PMVP icon
429
PMV Pharmaceuticals
PMVP
$69M
-2,589
Closed -$3.63K
PYXS icon
430
Pyxis Oncology
PYXS
$324M
-34,632
Closed -$76.9K
RARE icon
431
PUT
Ultragenyx Pharmaceutical
RARE
$1.51B
-320
Closed -$215K
RC
432
CALL
Ready Capital
RC
$289M
-527
Closed -$6.59K
RCEL icon
433
CALL
Avita Medical
RCEL
$346M
-1,464
Closed -$22.2K
RLAY icon
434
Relay Therapeutics
RLAY
$4.17B
-10,280
Closed -$53.7K
RNAM
435
DELISTED
Avidity Biosciences
RNAM
-6,864
Closed -$443K
RVPH
436
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
-29,695
Closed -$330K
SCI icon
437
Service Corp International
SCI
$11.2B
-3,688
Closed -$307K
SCPH
438
CALL
DELISTED
scPharmaceuticals
SCPH
-1,066
Closed -$339K
SGRY icon
439
Surgery Partners
SGRY
$1.87B
-9,704
Closed -$210K
SHY icon
440
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
-10,000
Closed -$830K
SLG icon
441
CALL
SL Green Realty
SLG
$3.94B
-90
Closed -$16.9K
SLNO
442
PUT
DELISTED
Soleno Therapeutics
SLNO
-230
Closed -$12.8K
SMBK icon
443
SmartFinancial
SMBK
$887M
-7,485
Closed -$267K
SMMT icon
444
CALL
Summit Therapeutics
SMMT
$14B
-175
Closed -$38.1K
SPY icon
445
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$815B
-20
Closed -$15.2K
SPY icon
446
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
-46
Closed -$6.14K
SRRK icon
447
CALL
Scholar Rock
SRRK
$6.74B
-229
Closed -$35.5K
SUPN icon
448
Supernus Pharmaceuticals
SUPN
$2.53B
-5,159
Closed -$247K
TIGR
449
UP Fintech Holding
TIGR
$914M
-11,688
Closed -$125K
TLTW icon
450
PUT
iShares 20+ Year Treasury Bond BuyWrite Strategy ETF
TLTW
$1.82B
-621
Closed -$1.86K

Similar funds

Persistent Asset Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Persistent Asset Partners held 464 positions worth $223M, up 53% from $145M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Persistent Asset Partners deployed $50.2M of net new capital in Q4 2025, opening 223 new positions and adding to 67 existing holdings. Its largest new stake was Molina Healthcare: 51,285 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.15M trimmed.

  • Persistent Asset Partners's largest Q4 2025 buy was Molina Healthcare: 51,285 shares worth $8.9M.
  • Persistent Asset Partners added most to Elevance Health in Q4 2025, an estimated $5.15M increase.
  • Persistent Asset Partners's biggest Q4 2025 reduction was UnitedHealth, cutting an estimated $3.15M.
  • Persistent Asset Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2025, selling an estimated $4.82M.
  • Persistent Asset Partners's ten largest holdings make up 25% of its $223M portfolio in Q4 2025.
  • Persistent Asset Partners opened 223 new positions and closed 103 in Q4 2025.
  • Persistent Asset Partners's portfolio value rose 53% quarter-over-quarter to $223M.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.